Pelago Stock

www.pelagohealth.comHealthcare / Digital HealthFounded: 2017Funding to Date: $137.72MM

With a mission to improve lives through substance abuse counseling solutions, Pelago is a company that offers a virtual health clinic. The company offers its virtual care by partnering with healthcare payors at enterprises to provide counseling services to employees. Pelago was formerly known as Quit Genius and was founded in 2017 by Maroof Ahmed, Yusuf Sherwani, and Sarim Siddiqui and is headquartered in New York, NY. Pelago offers a wide range of substance abuse support services including cognitive behavioral therapy and medication-assisted treatment as well as preventive education, primarily for tobacco, alcohol, and opioid abuse.

Register To Buy and Sell Shares

For more details on financing and valuation for Pelago, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Pelago’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Pelago.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Yusuf Sherwani MD
Co-Founder & Chief Executive Officer
Maroof Ahmed MD
Co-Founder & Chief Operating Officer
Sarim Siddiqui MD
Co-Founder & President
Ingrid Kessler
Chief People and Administrative Officer
Michael Reiff
Chief Product Officer
Ed Daley
Chief Commercial Officer
Paige Swanepoel
Chief Marketing Officer
Suzette Glasner Ph.D
Chief Scientific Officer

Board Members

Laura Connell
William Gibbs
Octopus Ventures

Frequently Asked Questions About Pelago’s Stock

Can you buy Pelago’s stock?
Pelago is not publicly traded on NYSE or NASDAQ in the U.S. To buy Pelago’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Pelago’s stock?
Yes, you can sell stock of a private company like Pelago. Forge can help you sell your Pelago stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Pelago’s stock price?
Pelago is a privately held company and therefore does not have a public stock price. However, you may access Pelago’s private market stock price with Forge Data.
What is Pelago’s stock ticker symbol?
Pelago does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

YC-backed Pelago, a virtual clinic for addiction treatment, raises $58M Series C
Pelago, Y Combinator-backed telehealth company that uses cognitive behavioral therapy (CBT) to help treat people with tobacco, alcohol and opioid addictions, said Thursday it had raised a $58 million Series C round. The recent funding, which brings its total raised to $151 million since being founded in 2017, comes two and a half years after Pelago, formerly known as Quit Genius, closed a Series B of $64 million amid the COVID pandemic.
Updated on: May 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.